The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention

Journal of the American College of Cardiology

Volumn 60, Issue 20, 2012, Pages 2005-2016

  Singla, Sandeep ^a   Sachdeva, Rajesh ^a   Uretsky, Barry F ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

antiplatelet therapy; cardiac risk; noncardiac surgery; percutaneous coronary intervention; perioperative period; stent; stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CANGRELOR; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; PRASUGREL; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y12 RECEPTOR INHIBITOR; THIENOPYRIDINE DERIVATIVE; TICAGRELOR; TIROFIBAN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; BARE METAL STENT; BLEEDING; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; DRUG USE; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; INCIDENCE; NONCARDIAC SURGERY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; RISK REDUCTION; STENT THROMBOSIS; SURGERY; TREATMENT OUTCOME;

HEMORRHAGE; HUMANS; INCIDENCE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; STENTS; THROMBOSIS;

EID: 84868557288     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.04.062     Document Type: Review

References (53)

1. D. Lloyd-Jones, R. Adams, M. Carnethon Heart disease and stroke statistics Circulation 119 2009 e21 e181
2. J.W. van Werkum, A.A. Heestermans, F.I. de Korte Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis Circulation 119 2009 828 834
3. J.W. van Werkum, A.A. Heestermans, A.C. Zomer Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis registry J Am Coll Cardiol 53 2009 1399 1409
4. I. Ferreira-Gonzalez, J.R. Marsal, A. Ribera Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation Circulation 122 2010 1017 1025
5. N.L. Cruden, S.A. Harding, A.D. Flapan Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery Circ Cardiovasc Interv 3 2010 236 242
6. P.B. Berger, N.S. Kleiman, M.J. Pencina Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement: results from the EVENT registry J Am Coll Cardiol Intv 3 2010 920 927
7. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine; Society for Vascular Surgery L.A. Fleisher, J.A. Beckman, K.A. Brown 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery J Am Coll Cardiol 54 2009 e13 e118
8. S. Rajagopalan, I. Ford, P. Bachoo Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery J Thromb Haemost 5 2007 2028 2035
9. P.C. Haggart, D.J. Adam, P.F. Ludman, C.A. Ludman, A.W. Bradbury Myocardial injury and systemic fibrinolysis in patients undergoing repair of ruptured abdominal aortic aneurysm Eur J Vasc Endovasc Surg 21 2001 529 534
10. T. Diamantis, N. Tsiminikakis, A. Skordylaki Alterations of hemostasis after laparoscopic and open surgery Hematology 12 2007 561 570
11. G.L. Kaluza, J. Joseph, J.R. Lee, M.E. Raizner, A.E. Raizner Catastrophic outcomes of noncardiac surgery soon after coronary stenting J Am Coll Cardiol 35 2000 1288 1294
12. S.H. Wilson, P. Fasseas, J.L. Orford Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting J Am Coll Cardiol 42 2003 234 240
13. A.K. Sharma, A.E. Ajani, S.M. Hamwi Major noncardiac surgery following coronary stenting Cathet Cardiovasc Interv 63 2004 141 145
14. P.R. Reddy, P.T. Vaitkus Risks of noncardiac surgery after coronary stenting Am J Cardiol 95 2005 755 757
15. P.Y. Brichon, P. Boitet, A. Dujon Perioperative in-stent thrombosis after lung resection performed within 3 months of coronary stenting Eur J Cardiothorac Surg 30 2006 793 796
16. G.A. Nuttall, M.J. Brown, J.W. Stombaugh Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention Anesthesiology 109 2008 588 595
17. P.A. Compton, A.A. Zankar, A.O. Adesanya, S. Banerjee, E.S. Brilakis Risk of noncardiac surgery after coronary drug-eluting stent implantation Am J Cardiol 98 2006 1212 1213
18. D.J. Brotman, M. Bakhru, W. Saber Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents J Hosp Med 2 2007 378 384
19. M. Conroy, S.N. Bolsin, S.A. Black, N. Orford Perioperative complications in patients with drug-eluting stents: a three-year audit at Geelong Hospital Anaesth Intensive Care 35 2007 939 944
20. S.J. Rhee, K.H. Yun, S.R. Lee Drug-eluting stent thrombosis during perioperative period Int Heart J 49 2008 135 142
21. G. Godet, Y. Le Manach, F. Lesache, S. Perbet, P. Coriat Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery Br J Anaesth 100 2008 472 477
22. J.A. Rabbitts, G.A. Nuttall, M.J. Brown Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents Anesthesiology 109 2008 596 604
23. C.U. Choi, S.W. Rha, Z. Jin The optimal timing for non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents Int J Cardiol 139 2010 313 316
24. K.K. Chia, J.J. Park, J. Postle, A. Cottrill, M.R. Ward Frequency of late drug-eluting stent thrombosis with non-cardiac surgery Am J Cardiol 106 2010 1 3
25. S. Anwaruddin, A.T. Askari, H. Saudye Characterization of post-operative risk associated with prior drug-eluting stent use J Am Coll Cardiol Intv 2 2009 542 549
26. A. Assali, H. Vaknin-Assa, E. Lev The risk of cardiac complications following noncardiac surgery in patients with drug eluting stents implanted at least six months before surgery Cathet Cardiovasc Interv 74 2009 837 843
27. N.K. Gandhi, A.R. Abdel-Karim, S. Banerjee, E.S. Brilakis Frequency and risk of noncardiac surgery after drug-eluting stent implantation Cathet Cardiovasc Interv 77 2011 972 976
28. E.S. Brilakis, D.J. Cohen, N.S. Kleiman Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation Am Heart J 161 2011 360 366
29. H.L. Kim, K.W. Park, J.J. Kwak Stent-related cardiac events after non-cardiac surgery Int J Cardiol 123 2008 353 354
30. O. Schouten, R.T. van Domburg, J.J. Bax Noncardiac surgery after coronary stenting J Am Coll Cardiol 49 2007 122 124
31. J.P. van Kuijk, W.J. Flu, O. Schouten Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents Am J Cardiol 104 2009 1229 1234
32. P. Albaladejo, E. Marret, C.M. Samama Non-cardiac surgery in patients with coronary stents: the RECO study Heart 97 2011 1566 1572
33. M.F. Brancati, M. Giammarinaro, F. Burzotta Outcome of non-cardiac surgery after stent implantation in the DES era J Invasive Cardiol 23 2011 44 49
34. M.N. Vicenzi, T. Meislitzer, B. Heitzinger, M. Halaj, L.A. Fleisher, H. Metzler Coronary artery stenting and non-cardiac surgery Br J Anaesth 96 2006 686 693
35. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Guidelines on myocardial revascularization Eur J Cardiothorac Surg 38 Suppl 2010 S1 S52
36. M. Joner, A.V. Finn, A. Farb Pathology of drug-eluting stents in humans J Am Coll Cardiol 48 2006 193 202
37. M. Ali, K. McDonald Very late bare-metal stent thrombosis, rare but stormy! J Invasive Cardiol 23 2011 E208 E210
38. M.L. Rossi, D. Zavalloni, G.L. Gasparini, P. Presbitero Very late multivessel thrombosis of bare metal stents with concomitant patent drug-eluting stents after withdrawal of aspirin Int J Cardiol 131 2008 e7 e9
39. N. Willis, R. Sachdeva, B.F. Uretsky Bare-metal stent thrombosis after noncardiac surgery greater than 10 years after stent implantation Cathet Cardiovasc Interv 78 2011 234 236
40. J. Daemen, P. Wenaweser, K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice Lancet 369 2007 667 678
41. H.S. Choi, M.H. Jeong, I.K. Seo Very late stent thrombosis in a drug-eluting stent due to interruption of anti-platelet agents in patients with acute myocardial infarction and thrombocytosis Korean Circ J 41 2011 417 420
42. D.G. de Souza, V.C. Baum, N.M. Ballert Late thrombosis of a drug-eluting stent presenting in the perioperative period Anesthesiology 106 2007 1057 1059
43. E.P. McFadden, E. Stabile, E. Regar Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 2004 1519 1521
44. E.S. Brilakis, J.L. Orford, P. Fasseas Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery Am J Cardiol 96 2005 512 514
45. D. Leibowitz, M. Cohen, D. Planer Comparison of cardiovascular risk of noncardiac surgery following coronary angioplasty with versus without stenting Am J Cardiol 97 2006 1188 1191
46. D.L. Bhatt, K.A. Fox, W. Hacke Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
47. A. Burdess, A.F. Nimmo, O.J. Garden Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia Ann Surg 252 2010 37 42
48. S. Savonitto, M. D'Urbano, M. Caracciolo Urgent surgery in patients with a recently implanted coronary drug-eluting stent Br J Anaesth 104 2010 285 291
49. E.G. Marcos, A.C. Da Fonseca, S.H. Hofma Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation Neth Heart J 19 2011 412 417
50. S.D. Wiviott, E. Braunwald, C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
51. L. Wallentin, R.C. Becker, A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
52. D.J. Angiolillo, P. Capranzano Pharmacology of emerging novel platelet inhibitors Am Heart J 156 Suppl 2008 S10 S15
53. D.J. Angiolillo, M.S. Firstenberg, M.J. Price Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial JAMA 307 2012 265 274